Synthetic Gels
to Standardize
Patient-Derived Organoids

watch the overview
is QGel

QGel provides tunable synthetic extracellular matrices (ECMs) for in vitro cellular based studies. QGel disease models recapitulate desired key physiological features of the human body and support the culture of any cell type, including:

Freshly isolated patient cells • Patient-derived organoids • Cells from PDX · Cell lines

QGel cell based assays can be used for applications in:

Drug discovery • Clinical decision making

Benefits of synthetic ECMs:

Reproducible • Industrially scalable • Suitable for clinical decision making


Find out more
with QGel

Order online

QGel has a range of cell specific ECMs ready to ship. Visit our webshop and browse by any number of filter options. Each product comes with easy to use protocols to ensure the seamless integration of assays into your labs.

Visit the webshop

ECM identification for any application

QGel has an extensive library of gels that differ in key biological, biophysical and biochemical characteristics. Our ECM screening process identifies which ECM and media conditions will best support the needs of your research.

Learn about our ECM ID Program

Our mission

At QGel, we are passionate about providing solutions for the discovery of next generation drugs and accelerating patient access to personalized medicine.

In pursuit of our mission, we design industry-grade synthetic extracellular matrices that better approximate the human situation.

Backed by evidence-based science, QGel’s technology empowers biotech, pharmaceutical companies and health care centers with biologically accurate disease models for applications in drug discovery and patient diagnostics.

Learn more about QGel
“Clinical applications will warrant a transition to more-defined and mechanically-dynamic matrices to fully exploit the potential of organoid technologies.“
Dutta, D., Heo, I., Clevers, H., Disease Modeling in Stem Cell-Derived 3D Organoid Systems. Trends in Molecular Medicine (2017)
“The full potential of organoids in research and therapy has remained unrealized, owing to the poorly defined animal-derived matrices in which they are grown.“
Gjorevski, N. et al., Designer matrices for intestinal stem cell and organoid culture. Nature (2016)
“Half of the secret of the cell lies outside the cell.“
Bissell MJ, Modelling Molecular Mechanisms of Breast Cancer and Invasion: Lessons from the Normal Gland. Biochemical Society transactions (2007)
“Scientists are starting to realize just how much a cell’s context matters.“
Bissell MJ, Abbott, A et al. Cell culture: Biology’s new dimension. Nature. (2003)
2018 September 10-13
EMBO | EMBL Symposium. Organoids: Modelling Organ Development and Disease in 3D Culture

Heidelberg, Germany

Will you be at the EMBO | EMBL Organoid Symposium in Heidelberg?  Contact us below if you would like to meet someone from the QGel team.

2018 September 21-24
AACR | Pancreatic Cancer: Advances in Science and Clinical Care

Boston, MA

Will you be at the AACR conference in Boston, MA?  Contact us below if you would like to meet someone from the QGel team

2018 September 27-30
AACR | Intestinal Stem Cells and Colon Cancer: Biology to Therapy

Washington, DC

Will you be at the AACR Conference in Washington, DC?  Contact us below if you would like to meet someone from the QGel team

2018 November 5-7
EACR: Precision Medicine

Bergamo, Italy

Will you be at the EACR conference in Bergamo, Italy?  Contact us below if you would like to meet someone from the QGel team

2018 November 15-17
AACR | Precision Medicine in Solid Tumors

Seoul, South Korea

Will you be at the AACR Conference in Seoul, South Korea?  Contact us below if you would like to meet someone from the QGel team

Contact us